DA Davidson Upgrades Joint to Neutral, Raises Price Target to $15
DA Davidson analyst Linda Bolton Weiser upgrades Joint (NASDAQ:JYNT) from Underperform to Neutral and raises the price target from $12 to $15.
Earnings Scheduled For March 9, 2023
Companies Reporting Before The Bell
• Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.
$1.4 Million Bet On Joint Corp? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed lower on Tuesday, there were a few notable insider trades.
The Joint Chiropractic Expands To Alaska, Signs Franchise Agreement For Three Clinics
-First The Joint clinic opens in Wasilla, Alaska-
SCOTTSDALE, Ariz., Dec. 6, 2022 /PRNewswire/ -- The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 236 companies set new 52-week lows.
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
$3.8 Million Bet On This Technology Stock? 3 Stocks Insiders Are Buying
Although US stocks traded mostly lower on Tuesday, there were a few notable insider trades.
The Joint Chiropractic Becomes The Official Chiropractor Of The USC Trojans
SCOTTSDALE, Ariz., Sept. 8, 2022 /PRNewswire/ -- The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The Joint
4 Analysts Have This to Say About Joint
Joint (NASDAQ:JYNT) has observed the following analyst ratings within the last quarter:
Maxim Group Upgrades Joint to Buy, Announces $36 Price Target
Maxim Group analyst Anthony Vendetti upgrades Joint (NASDAQ:JYNT) from Hold to Buy and announces $36 price target.